Is adjuvant immunotherapy effective in patients with urothelial cancer?

Minerva Urol Nephrol. 2022 Jun;74(3):252-254. doi: 10.23736/S2724-6051.22.04841-8. Epub 2022 Feb 11.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carcinoma, Transitional Cell* / therapy
  • Humans
  • Immunologic Factors
  • Immunotherapy
  • Urinary Bladder Neoplasms* / therapy

Substances

  • Immunologic Factors